Novo Nordisk A/S (NVO: Quote), the world's largest insulin maker, said Monday that on January 31 it initiated a share repurchase program in accordance with the provisions of the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase up to DKK 3.0 billion of B shares the period from January 31 to April 29.
Transactions related to Novo Nordisk's incentive programs have resulted in a net sale by Novo Nordisk of 783,652 B shares in the period from January 31 to February 8. The shares in those transactions were not part of the Safe Harbour repurchase program.
Novo Nordisk expects to repurchase up to DKK 14.0 billion of B shares f during a 12 month period beginning January 31, 2013. As of February 8, the company said it has repurchased a total of 334,310 B shares for an aggregate value of about DKK 352.5 milion.
The total amount of shares in the company is 560 million including treasury shares.
by RTT Staff Writer
For comments and feedback: email@example.com